Summary
The study trained an AI system on electrocardiogram data paired with biopsy-linked biomarkers from transplant recipients. The researchers present it as a potential way to identify rejection earlier while reducing reliance on invasive biopsies.
Why it matters
The work shows how multimodal clinical AI is moving toward decision support in high-risk medicine, although prospective validation and clinical integration remain necessary.
Related coverage
- Predactiv details a behavioral AI foundation model for marketing
- Primitive Labs receives Sony backing for models of human behaviour
- Techman Robot earns IEC 62443 security certification for an AI cobot